|
시장보고서
상품코드
2049327
어레이 계측기 시장 보고서 : 용도별, 기술별, 최종사용자별, 지역별(2026-2034년)Array Instruments Market Report by Application, Technology, End-User, and Region 2026-2034 |
||||||
세계의 어레이 계측기 시장 규모는 2025년에 12억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 17억 달러에 달하고, 2026년부터 2034년까지 CAGR 3.27%로 성장할 것으로 예측했습니다.
어레이 계측기는 여러 유전자의 발현을 정량적으로 동시에 모니터링하기 위해 실험실에서 사용됩니다. 이 장비에는 수백 개의 서로 다른 사례에서 채취한 수많은 대표 조직 샘플이 포함되어 있으며, 이들은 하나의 조직학 슬라이드에 배치되어 있습니다. 어레이 계측기의 높은 처리량 접근 방식은 유전자형에서 염색체 발현 및 돌연변이를 식별하고, 메신저 RNA(mRNA) 또는 단백질 수준에서 유전자 발현을 측정하고 검출하는 데 도움이 됩니다. 그 결과, 분자생물학, 세포생물학, 유전학, 분자병리학, 핵산 합성 및 염기서열 분석에 응용되고 있습니다.
만성 질환의 유병률 증가와 조기 발견 및 진단에 대한 새로운 요구가 증가하면서 세계 어레이 계측기 시장의 성장을 이끄는 주요 요인 중 하나로 작용하고 있습니다. 이와 더불어, 많은 국가의 정부가 의료 시설 개선에 투자하고 있으며, 이는 특히 신흥국에서 어레이 계측기의 수요에 긍정적인 영향을 미치고 있습니다. 또한, 이 장비들은 다양한 기술과의 통합이 가능하여 생명과학, 신약개발 등 다양한 연구 분야에 적용될 수 있을 것으로 기대됩니다. 예를 들어, 데옥시리보핵산(DNA) 마이크로어레이는 상보적 DNA의 형광표지를 통해 유전자 발현의 변화를 조사하는 데 사용됩니다. 한편, 조직 마이크로어레이는 새로운 진단 및 예후 마커를 발굴하고 인간 암 치료의 표적화에 기여하고 있습니다. 이 외에도 마이크로어레이를 이용한 비교 유전체 하이브리드화(Array CGH)와 같은 첨단 기술의 도입은 향후 몇 년 동안 시장 성장을 촉진할 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 어레이 계측기 시장
제6장 시장 내역 : 용도별
제7장 시장 내역 : 기술별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 지표
제14장 경쟁 구도
KSM 26.06.09The global array instruments market size reached USD 1.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 1.7 Billion by 2034, exhibiting a growth rate (CAGR) of 3.27% during 2026-2034.
An array instrument is used in laboratories for quantitatively and simultaneously monitoring the expression of multiple genes. It contains numerous small representative tissue samples from hundreds of different cases, which are assembled on a single histologic slide. The high-throughput approach of the array instrument aids in locating chromosomal expressions and mutations in a genotype, as well as measuring and detecting gene expressions at the messenger RNA (mRNA) or protein level. As a result, it finds applications in molecular and cell biology, genetics, molecular pathology, and for synthesizing and sequencing nucleic acids.
The increasing prevalence of chronic diseases, in confluence with the emerging need for their early detection and diagnosis, represents one of the key factors driving the global array instruments market growth. In addition to this, governments of several countries are investing in the improvement of healthcare facilities, which in turn, is positively influencing the demand for array instruments, especially in emerging economies. Furthermore, these instruments can be incorporated with a wide range of technologies, owing to which they find applications in different areas of research, such as life sciences and drug discovery. For instance, deoxyribonucleic acid (DNA) microarrays are used for examining changes in gene expression by fluorescent labeling of complementary DNA, whereas tissue microarrays aid in identifying new diagnostic and prognostic markers and targeting cancer in human beings. Other than this, the introduction of advanced technologies, such as microarray-based comparative genomic hybridization (array CGH), is expected to bolster the market growth in the upcoming years.
KEY MARKET SEGMENTATION:
Breakup by Application:
- Molecular Biology
- Cell Biology
- Genetics
- Molecular Pathology
- Others
Breakup by Technology:
- DNA Microarrays
- Protein Microarrays
- Cellular Microarrays
- Tissue Microarrays
Breakup by End-User:
- Research and Development Laboratories
- Clinical Diagnostic Labs
- Agriculture Research Centers
- Veterinary Laboratories
- Forensic Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report has also analysed the competitive landscape of the market with some of the key players being Affymetrix Inc., Agilent Technologies Inc., Arrayit Corporation, Bio-RAD Laboratories, Inc. Illumina Inc., Laboratory Corporation, Molecular Devices LLC, Raybiotech Inc., Sigma Aldrich Corporation, Thermo Fisher Scientific Inc., etc.
Key Questions Answered in This Report
1. How big is the array instruments market?
2. What is the future outlook of array instruments market?
3. What are the key factors driving the array instruments market?
4. Which are the leading companies in the global array instruments market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Array Instruments Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Application
- 6.1 Molecular Biology
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Cell Biology
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Genetics
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Molecular Pathology
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Technology
- 7.1 DNA Microarrays
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Protein Microarrays
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cellular Microarrays
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Tissue Microarrays
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End-User
- 8.1 Research and Development Laboratories
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinical Diagnostic Labs
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Agriculture Research Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Veterinary Laboratories
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Forensic Centers
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Affymetrix Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Agilent Technologies Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Arrayit Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Bio-RAD Laboratories Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Illumina Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Laboratory Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Molecular Devices LLC
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Raybiotech Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sigma Aldrich Corporation
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Thermo Fisher Scientific Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Affymetrix Inc.
